Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Murthy

Showing results (801-810 of 873) with videos related to

Pageof 88
Sort By:
Anaerobe|July 19, 2025
Molecular characterization of Clostridioides difficile isolated from older adults during prospective population-based active surveillance at nine hospitals in Tokyo, Japan, 2018-2020Zhenghui Li, Ashlesh K Murthy, C Hal Jones, et al.
Cancers|July 29, 2023
The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for CancerJerome Canady, Saravana R K Murthy, Taisen Zhuang, et al.
Cancer Discovery|October 18, 2022
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup AnalysisGuy Jerusalem, Yeon Hee Park, Toshinari Yamashita, et al.
The Journal of Chemical Physics|June 28, 2013
Hydrogen termination of CVD diamond films by high-temperature annealing at atmospheric pressureV Seshan, D Ullien, A Castellanos-Gomez, et al.
Clinical Immunology (Orlando, Fla.)|January 24, 2021
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancerR Connor Chick, G Travis Clifton, Diane F Hale, et al.
Clinical Breast Cancer|August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution ExperienceRashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.
The Journal of Experimental Medicine|April 15, 2015
Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axisMiguel F Diaz, Nan Li, Hyun Jung Lee, et al.
Vaccine|August 6, 2014
A multicenter prospective hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children less than five years of age in IndiaT Saluja, S D Sharma, M Gupta, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 22, 2014
Short-term outcomes for preterm infants with surgical necrotizing enterocolitisK Murthy, T D Yanowitz, R DiGeronimo, et al.
NPJ Breast Cancer|December 15, 2017
A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline <i>BRCA</i> mutation demonstrates marked activityJ K Litton, M Scoggins, D L Ramirez, et al.
Pageof 88

Showing results (801-810 of 873) with videos related to

Sort By:
Pageof 88
Anaerobe|July 19, 2025
Molecular characterization of Clostridioides difficile isolated from older adults during prospective population-based active surveillance at nine hospitals in Tokyo, Japan, 2018-2020Zhenghui Li, Ashlesh K Murthy, C Hal Jones, et al.
Cancers|July 29, 2023
The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for CancerJerome Canady, Saravana R K Murthy, Taisen Zhuang, et al.
Cancer Discovery|October 18, 2022
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup AnalysisGuy Jerusalem, Yeon Hee Park, Toshinari Yamashita, et al.
The Journal of Chemical Physics|June 28, 2013
Hydrogen termination of CVD diamond films by high-temperature annealing at atmospheric pressureV Seshan, D Ullien, A Castellanos-Gomez, et al.
Clinical Immunology (Orlando, Fla.)|January 24, 2021
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancerR Connor Chick, G Travis Clifton, Diane F Hale, et al.
Clinical Breast Cancer|August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution ExperienceRashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.
The Journal of Experimental Medicine|April 15, 2015
Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axisMiguel F Diaz, Nan Li, Hyun Jung Lee, et al.
Vaccine|August 6, 2014
A multicenter prospective hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children less than five years of age in IndiaT Saluja, S D Sharma, M Gupta, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 22, 2014
Short-term outcomes for preterm infants with surgical necrotizing enterocolitisK Murthy, T D Yanowitz, R DiGeronimo, et al.
NPJ Breast Cancer|December 15, 2017
A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline <i>BRCA</i> mutation demonstrates marked activityJ K Litton, M Scoggins, D L Ramirez, et al.
Pageof 88